Brief: In8bio, Inc. - Announced Issuance Of Additional European Patent Covering Composition Of Matter For Co's Drug Resistant Immunotherapy (Dri) Platform
21/07/2022 12:43
July 21 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO, INC. - ANNOUNCED ISSUANCE OF ADDITIONAL EUROPEAN
PATENT
COVERING COMPOSITION OF MATTER FOR CO'S DRUG RESISTANT
IMMUNOTHERAPY (DRI) PLATFORM
Source text for Eikon: ID:nGNXYlfLw
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall